Browsing SIHF Open Archive by Author "Hollan, Ivana"
Now showing items 1-8 of 8
-
Acute effects of post-absorptive and postprandial moderate exercise on markers of inflammation in hyperglycemic individuals
Nygård, Håvard; Slettaløkken, Gunnar; Whist, Jon Elling; Hollan, Ivana; Ellefsen, Stian; Holmboe-Ottesen, Gerd; Rønnestad, Bent; Høstmark, Arne Torbjørn (Peer reviewed; Journal article, 2017)Abstract Purpose Systemic inflammation is involved in the development of several diseases, including cardiovascular disease and type 2 diabetes. It is known that vigorous exercise affects systemic inflammation, but less ... -
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Deyab, Gia; Hokstad, Ingrid; Whist, Jon Elling; Småstuen, Milada Cvancarova; Agewall, Stefan; Lyberg, Torstein; Bottazzi, Barbara; Meroni, Pier Luigi; Leone, Roberto; Hjeltnes, Gunnbjørg; Hollan, Ivana (Peer reviewed; Journal article, 2017)Background Pentraxin 3 is proposed to be a marker of inflammation and cardiovascular risk, but its role in inflammatory rheumatic diseases (IRDs) is still uncertain. Therefore, we wanted to examine if anti-rheumatic ... -
Differential expression of Vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis
Oma, Ingvild; Olstad, Ole Kristoffer; Andersen, Jacqueline Kirsti; Lyberg, Torstein; Molberg, Øyvind; Fostad, Ida; Fagerland, Morten; Almdahl, Sven Martin; Rynning, Stein Erik; Yndestad, Arne; Aukrust, Pål; Whist, Jon Elling; Hollan, Ivana (Journal article; Peer reviewed, 2018)BACKGROUND: Vitamin D has an important role in the immune system, and has been linked to rheumatoid arthritis (RA) and coronary artery disease (CAD). The exact mechanisms by which vitamin D is involved in these processes ... -
Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: A biopsy study
Andersen, Jacqueline Kirsti; Oma, Ingvild; Prayson, Richard A.; Kveldstad, Ingjerd Lien; Almdahl, Sven Martin; Fagerland, Morten; Hollan, Ivana (Peer reviewed; Journal article, 2016)Background The cause of premature cardiovascular disease (CVD) in inflammatory rheumatic diseases (IRDs) has not been fully elucidated. As inflammation may play a role, we wanted to compare the occurrence and extent of ... -
Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: A cross-sectional study
Holm, Sverre; Oma, Ingvild; Hagve, Tor-Arne; Saatvedt, Kjell; Brosstad, Frank Roger; Mikkelsen, Knut; Rydningen, Hans; Risnes, Ivar; Almdahl, Sven Martin; Ueland, Thor; Aukrust, Pål; Halvorsen, Bente; Hollan, Ivana (Journal article; Peer reviewed, 2019)OBJECTIVES: Patients with various inflammatory rheumatic diseases (IRDs) have increased risk of atherothrombotic disease. Lipoprotein (a) (Lp(a)) is a risk factor for atherosclerosis but its role in IRD with accompanying ... -
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Deyab, Gia; Hokstad, Ingrid; Whist, Jon Elling; Småstuen, Milada C; Agewall, Stefan; Lyberg, Torstein; Ronda, Nicoletta; Mikkelsen, Knut; Hjeltnes, Gunnbjørg; Hollan, Ivana (Journal article; Peer reviewed, 2017)Background Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence probably due to atherosclerosis. ... -
Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases
Shields, Kelly J.; Mollnes, Tom Eirik; Eidet, Jon Roger; Mikkelsen, Knut; Almdahl, Sven Martin; Bottazzi, Barbara; Lyberg, Torstein; Manzi, Susan; Ahearn, Joseph M.; Hollan, Ivana (Journal article; Peer reviewed, 2017)Purpose Inflammatory rheumatic diseases (IRD) are associated with accelerated coronary artery disease (CAD), which may result from both systemic and vascular wall inflammation. There are indications that complement may ... -
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
Hokstad, Ingrid; Deyab, Gia; Fagerland, Morten; Lyberg, Torstein; Hjeltnes, Gunnbjørg; Førre, Øystein Thorleiv; Agewall, Stefan; Mollnes, Tom Eirik; Hollan, Ivana (Journal article; Peer reviewed, 2019)Background The complement system is involved in pathogenesis of cardiovascular disease, and might play a role in accelerated atherogenesis in spondylarthropathies (SpA). Hence, we examined complement activation in SpA, and ...